[Federal Register Volume 66, Number 185 (Monday, September 24, 2001)]
[Notices]
[Page 48876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-23747]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates:

      8:30 a.m.-6:15 p.m., October 17, 2001.
      8 a.m.-4:15 p.m., October 18, 2001.

    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE, Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The agenda will include a discussion on 
rotavirus vaccine and intussusception; live attenuated influenza 
vaccine and potential pediatric influenza vaccine recommendations; 
update on 2001-2002 influenza vaccine supply; hepatitis B 
recommendation; update on varicella disease and varicella vaccine in 
the United States: vaccine coverage, vaccine safety and 
effectiveness, status of child care and school requirements, and 
decline in varicella disease from active and passive surveillance 
data; pneumococcal conjugate vaccine: effect of the vaccine on 
invasive disease during 2000 and on vaccine supply; Institute of 
Medicine recommendations on thimerosal; updates from the National 
Immunization Program, Food and Drug Administration, Vaccine Injury 
Compensation Program, National Institutes of Health, National 
Vaccine Program, and the National Center for Infectious Diseases; 
recommended childhood immunization schedule; use of oral polio virus 
to control outbreaks of poliomyelitis; adult harmonized schedule; 
receipt of rubella vaccine before pregnancy; Occupational Safety and 
Health Administration requirement for using safety engineered 
needles and implications for childhood immunization delivery; 
adaptation of vaccine formulary selection algorithm to web-
accessible tool; and hepatitis A vaccine.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: September 18, 2001.
John Burckhardt,
Acting Director, Management Analysis and Services Office.
[FR Doc. 01-23747 Filed 9-21-01; 8:45 am]
BILLING CODE 4163-18-P